The Myelodysplastic Syndromes Channel is supported with funding from Geron (Silver).
The Myeloproliferative Neoplasms Channel is supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
SOHO 2024 | Diagnosing MDS/MPN overlap syndromes: challenges that remain
In this video, Eric Padron, MD, Moffitt Cancer Center, Tampa, FL, discusses the diagnosis of myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) overlap syndromes, particularly chronic myelomonocytic leukemia (CMML), highlighting their unique position between WHO and ICC classification systems. Dr Padron emphasizes that the incidence of CMML has historically been underestimated due to diagnostic challenges. This interview took place at the Twelfth Annual Meeting of the Society of Hematologic Oncology (SOHO 2024) congress in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
